Caspase-mediated cell death in hematological malignancies: Theoretical considerations, methods of assessment, and clinical implications

Leukemia and Lymphoma

Volumn 44, Issue 7, 2003, Pages 1089-1104

  Smolewski, Piotr ^a   Darzynkiewicz, Zbigniew ^b   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Apoptosis; Caspases; Clinical implications; Hematological malignancies; Leukemia

Indexed keywords

2 METHOXYESTRADIOL; ALPHA INTERFERON; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; BCR ABL PROTEIN; BETA LAPACHONE; BUTHIONINE SULFOXIMINE; CASPASE; CD86 ANTIGEN; CLADRIBINE; CYTARABINE; CYTOSTATIC AGENT; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GLUCOCORTICOID; I KAPPA B; IMATINIB; LYMPHOCYTE ANTIBODY; NUCLEOSIDE ANALOG; PROTEIN INHIBITOR; PROTEIN KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RITUXIMAB; SYNAPTOPHYSIN; TAXANE DERIVATIVE; THALIDOMIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG;

ACUTE LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BINDING ASSAY; CARCINOGENESIS; CELL STRUCTURE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DNA DETERMINATION; DRUG CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ASSAY; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; LYMPHOMA; MEDICAL RESEARCH; MITOCHONDRIAL MEMBRANE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVIEW; TREATMENT PLANNING;

ANIMALS; APOPTOSIS; CASPASES; HEMATOLOGIC NEOPLASMS; HUMANS;

EID: 0038324375     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000077007     Document Type: Review

References (192)

1. Kitada, S., Pedersen, I.M., Schimmer, A.D. and Reed, J.C. (2002) "Dysregulation of apoptosis genes in hematopoietic malignancies", Oncogene 21, 3459-3474.
2. Blagosklonny, M.V. (2000) "The dilemma of apoptosis in myelodysplasia and leukemia: a new promise of therapeutic intervention?", Leukemia 14, 2017-2018.
3. Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Snow, B.E., Brothers, G.M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D.R., Aebersold, R., Siderovski, D.P., Penninger, J.M. and Kroemer, G. (1999) "Molecular characterization of mitochondrial apoptosis-inducing factor", Nature 97, 441-446.
4. Penninger, J.M. (2001) "Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death", Nature 410, 549-554.
5. Perez-Galan, P., Marzo, I., Giraldo, P., Rubio-Felix, D., Lasierra, P., Larrad, L., Anel, A. and Naval, J. (2002) "Role of caspases and apoptosis-inducing factor (AIF) in cladribine-induced apoptosis of B cell chronic lymphocytic leukemia", Leukemia 16, 2106-2114.
6. Earnshaw, W.C., Martins, L.M. and Kaufmann, S.H. (1999) "Mammalian caspases: structure, activation, substrates, and functions during apoptosis", Annu. Rev. Biochem. 68, 383-424.
7. Ekert, P.G., Silke, J. and Vaux, D.L. (1999) "Caspase inhibitors", Cell Death Differ. 6, 1081-1086.
8. Nicholson, D.W. (1999) "Caspase structure, proteolytic substrates and function during apoptotic cell death", Cell Death Differ. 6, 1028-1042.
9. Stennicke, H.R. and Salvesen, G.S. (1999) "Catalytic properties of the caspases", Cell Death Differ. 6, 1054-1059.
10. Stennicke, H.R. and Salvesen, G.S. (2000) "Caspases - controlling intracellular signals by protease zymogen activation", Biochem. Biophys. Acta 1477, 299-306.
11. Chinnaiyan, A.M., O'Rourke, K., Yu, G.L., Lyons, R.H., Garg, M., Duan, D.R., Xing, L., Gentz, R., Ni, J. and Dixit, V.M. (1996) "Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95", Science 274, 990-992.
12. Itoh, N. and Nagata, S. (1993) "A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen", J. Biol. Chem. 268, 10932-10937.
13. Gong, B. and Almasan, A. (2000) "Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells", Cancer Res. 60, 5754-5760.
14. Pan, G., O'Rourke, K., Chinnayan, A.M., Gentz, R., Ebner, R., Ni, J. and Dixit, V.M. (1997) "The receptor for the cytotoxic ligand TRAIL", Science 276, 111-113.
15. Kim, Y., Suh, N., Sporn, M. and Reed, J.C. (2002) "An inducible pathways for degradation of FLIP protein sensitises tumor cells to TRAIL-induced apoptosis", J. Biol. Chem. 277, 22320-22329.
16. Thornberry, N.A., Rano, T.A., Peterson, E.P., Rasper, D.M., Timkey, T., Garcia-Calvo, M., Houtzager, V.M., Nordstrom, P.A., Roy, S., Valliancourt, J.P., Chapman, K.T. and Nicholson, D.W. (1997) "A combinatorial approach defines specificities of members of the caspase family and granzyme B", J. Biol. Chem. 272, 17907-17911.
17. Xiao, C., Yang, B.F., Asadi, N., Beguinot, F. and Hao, C. (2002) "Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells", J. Biol. Chem. 277, 25020-25025.
18. Gouloumet, V., Metivier, D., Stancou, R., Mami-Chouaib, F., Kroemer, G. and Chouaib, S. (2002) "Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: role of caspase-8 and mitochondria", Cancer Gene Ther. 9, 219-227.
19. Schrantz, N., Blanchart, D.A., Auffredou, M.T., Sharma, S., Leca, G. and Vazquez, A. (1999) "Role of caspases and possible involvement of retinoblastoma protein during TGFβ-mediated apoptosis of human B lymphocytes", Oncogene 18, 3511-3519.
20. Xu, S.Q. and El-Deiry, W.S. (2000) "p21 (WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4", Biochem. Biophys. Res. Commun. 269, 179-190.
21. Schrantz, N., Bourgeade, M.F., Mouhamad, S., Leca, G., Sharma, S. and Vazquez, A. (2001) "p38-mediated regulation of an Fas-associated death domain protein-independent pathway leading to caspase-8 activation during TGFbeta-induced apoptosis in human Burkitt lymphoma B cells BL41", Mol. Biol. Cell 12, 3139-3151.
22. Adams, J.M. and Corz, S. (2001) "Life-or-death decisions by the Bcl-2 protein family", Trends Biochem. Sci. 26, 61-66.
23. Zamzani, N., Brenner, C., Matzo, I., Susin, S.A. and Kroemer, G. (1998) "Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins", Oncogene 16, 2265-2282.
24. Bernardi, P., Petronili, V., Di Lisa, F. and Forte, M. (2001) "A mitochondrial perspective on cell death", Trends Biochem. Sci. 26, 112-117.
25. Ferri, K.F. and Kroemer, G. (2001) "Organelle-specific initiation of cell death pathways", Nat. Cell Biol. 3, E255-E263.
26. Bratton, S.B., Lewis, J., Butterworth, M., Duckett, C.S. and Cohen, G.M. (2002) "XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis", Cell Death Differ. 9, 881-892.
27. Ruiz-Vela, A., Gonzalez de Buitrago, G. and Martinez, A.C. (1999) "Implication of calpain in caspase activation during B cell clonal deletion", EMBO J. 18, 4988-4998.
28. Li, X., Du, L. and Darzynkiewicz, Z. (2000) "During apoptosis of HL-60 and U-937 cells caspases are activated independently of dissipation of mitochondrial electrochemical potential", Exp. Cell Res. 257, 290-297.
29. Slee, E.A., Keogh, S.A. and Martin, S.J. (2000) "Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalyzed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release", Cell Death Differ 7, 556-565.
30. Krajewska, M., Zapata, J.M., Meinhold-Heerlein, I., Hedayat, H., Monks, A., Bettendorf, H., Shabaik, A., Bubendorf, L., Kallioniemi, O.P., Kim, H., Reifenberger, G., Reed, J.C. and Krajewski, S. (2002) "Expression of bcl-2 family member bid in normal and malignant tissues", Neoplasia 4, 9-140.
31. Zapata, J.M., Takahashi, R., Salvesen, G.S. and Reed, J.C. (1997) "Granzyme release and caspase activation in activated human T-lymphocytes", J. Biol. Chem. 272, 13459-13462.
32. Grabarek, J., Dragan, M., Lee, B.W., Johnson, G.L. and Darzynkiewicz, Z. (2002) "Activation of chymotrypsin-like serine protease(s) during apoptosis detect by affinity-labeling of the enzymatic center with fluoresceinated inhibitor", Intern. J. Oncol. 20, 225-233.
33. Muerkoster, S., Weigand, M.A., Choi, C., Walczak, H., Schirrmacher, V. and Umansky, V. (2002) "Superantigen reactive Vbeta6 + T cells induce perforin/granzyme B mediated caspase-independent apoptosis in tumour cells", Br. J. Cancer 86, 828-836.
34. Rao, R.V., Castro-Obregon, S., Frankowski, H., Schuler, M., Stoka, V., del Rio, G., Bredesen, D.E. and Ellerby, H.M. (2002) "Coupling endoplasmic reticulum stress to the cell death program: an Apaf-1-independent intrinsic pathway", J. Biol. Chem. 277, 21836-21842.
35. Yoneda, T., Imaizumi, K., Oono, K., Yui, D., Gomi, F., Katayama, T. and Tohyama, M. (2001) "Activation of caspase-12, an endoplasmic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependend mechanisms in response to the ER stress", J. Biol. Chem. 276, 13935-13940.
36. Johnson, D.E. (2000) "Noncaspase proteases in apoptosis", Leukemia 14, 1695-1703.
37. Lamothe, B. and Aggarwal, B.B. (2002) "Ectopic expression of Bel-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60", J. Interferon Cytokine Res. 22, 269-279.
38. Barry, M., Heibein, J., Pinkoski, M. and Bleackley, R.C. (2000) "Quantitative measurement of apoptosis induced by cytotoxic T lymphocytes", Methods Enzymol. 322, 40-46.
39. Kraemer, G. (1998) "The mitochondrion as an integrator/coordinator of cell death pathways", Cell Death Differ. 5, 547-548.
40. Shapiro, H.M. (2000) "Membrane potential estimation by flow cytometry", Methods 21, 271-279.
41. Darzynkiewicz, Z., Traganos, F., Staiano-Coico, L., Kapuscinski, J. and Melamed, M.R. (1992) "Interactions of rhodamine 123 with living cells studied by flow cytometry", Cancer Res. 42, 799-806.
42. Johnsohn, L.V., Walsh, M.L. and Chen, L.B. (1980) "Localisation of mitochondria in living cells with rhodamine 123", Proc. Natl Acad. Sci. 77, 990-994.
43. Darzynkiewicz, Z., Li, X. and Gong, J. (1994) "Assays of cell viability. Discrimination of cells dying by apoptosis", Methods Cell Biol. 41, 16-39.
44. Finucane, D.M., Waterhouse, N.J., Amaranto-Mendes, G.P., Cotter, T.G. and Green, D.R. (1999) "Collapse of the inner mitochondrial transmembrane potential is not required for apoptosis of HL-60 cells", Exp. Cell Res. 251, 166-174.
45. Fadok, V.A., Voelker, D.R., Campbell, P.a., et al. (1992) "Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages", J. Immunol. 142, 2207-2216.
46. Van Engeland, M., Nieland, L.J.W., Ramaekers, F.C.S., Schutte, B. and Reutelingsperger, P.M. (1998) "Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidyl-serine exposure", Cytometry 31, 1-9.
47. Darzynkiewicz, Z., Bedner, E. and Smolewski, P. (2001) "Flow cytometry in analysis of cell cycle and apoptosis", Semin. Hematology 38, 179-193.
48. Arends, M.J., Morris, R.G. and Wyllie, A.H. (1990) "Apoptosis: the role of endonuclease", Am. J. Pathol. 136, 595-608.
49. Kerr, J.F.R., Wyllie, A.H. and Curie, A.R. (1972) "Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics", Br. J. Cancer 26, 239-257.
50. Bedner, E., Li, X., Gorczyca, W., Melamed, M.R. and Darzynkiewicz, Z. (1999) "Analysis of apoptosis by laser scanning cytometry", Cytometry 35, 181-195.
51. Darzynkiewicz, Z., Smolewski, P. and Bedner, E. (2002) "Use of flow and laser scanning cytometry to study mechanisms regulating cell cycle and controlling cell death", Hematol. Oncol. Clin. N. Am. 16, 339-355.
52. Gong, J., Traganos, F. and Darzynkiewicz, Z. (1994) "A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry", Ann. Biochem. 218, 314-319.
53. Darzynkiewicz, Z., Juan, G., Li, X., Murakami, T. and Traganos, F. (1997) "Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis)", Cytometry 27, 1-20.
54. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S.A. (1992) "Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation", J. Cell. Biol. 119, 493-501.
55. Gorczyca, W., Bruno, S., Darzynkiewicz, R.J., Gong, J. and Darzynkiewicz, Z. (1992) "DNA strand breaks occurring during apoptosis: their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors", Int. J. Oncol. 1, 639-648.
56. Darzynkiewicz, Z., Bedner, E. and Smolewski, P. (2002) "In situ detection of DNA strand breaks in analysis of apoptosis by flow-and laser scanning-cytometry", Methods Mol. Biol. 203, 69-77.
57. Li, X., Melamed, M.R. and Darzynkiewicz, Z. (1996) "Detection of apoptosis and DNA replication by differential labeling of DNA strand breaks with fluorochromes of different color", Exp. Cell Res. 222, 28-37.
58. Tobey, R.A. (1975) "Different drugs arrest cells at a number of distinct stages in G2", Nature 254, 245-247.
59. Zhang, T.S., Hunort, S., Kuida, K. and Flavell, R.A. (1999) "Caspase knockouts: matters of life and death", Cell Death Differ. 6, 1043-1053.
60. Gorman, A.M., Hirt, U.A., Zhivotovsky, B., Orrenius, S. and Ceccatelliu, S. (1999) "Application of a fluorometric assay to detect caspase activity in thymus tissue undergoing apoptosis in vivo", J. Immunol. Methods 226, 43-48.
61. Liu, J., Bhalgat, M., Zhang, C., Diwu, Z., Hoyland, B. and Klaubert, D.H. (1999) "Fluorescent molecular probes V: a sensitive caspase-3 substrate for fluorometric assays", Bioorg. Med. Chem. Lett. 9, 3231-3236.
62. Martinsson, P., Ekelund, S., Nygren, P. and Larsson, R. (2002) "The combination of antitumoral pyridyl cyanoguanidyne CHS 828 and etoposide in vitro- from cytotoxic synergy to complete inhibition of apoptosis", Br. J. Pharmacol. 137, 568-573.
63. Komoriya, A., Packard, B.Z., Brown, M.J., Wu, M.L. and Henkart, P.A. (2000) "Assessment of caspase activities in intact apoptetic thymocytes using cell-permeable fluorogenic caspase substrates", J. Exp. Med. 191, 1819-1828.
64. Hetz, C.A., Hunn, M., Rojas, P., Torres, V., Leyton, L. and Quest, A.F. (2002) "Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: onset of necrosis is associated with delayed ceramide increase", J. Cell Sci. 115, 4671-4683.
65. Belloc, F., Belaund-Rotureau, M.A., Lavignolle, V., Bascans, E., Braz-Pereira, E., Durrieu, F. and Lacombe, F. (2000) "Flow cytometry of caspase-3 activation in preapoptotic leukemic cells", Cytometry 40, 151-160.
66. Tanaka, M., Momoi, T. and Marunouchi, T. (2000) "In situ detection of activated caspase-3 in apoptotic granule neurons in the developing cerebellum in,slice cultures and in vivo", Brain Res. Dev. Brain Res. 21, 223-228.
67. Dukers, D.F., Meijer, C.J., ten Berge, R.L., Vos, W., Ossenkoppele, G.J. and Oudejans, J.J. (2002) "High numbers of active caspase 3-positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcome", Blood 100, 36-42.
68. Dukers, D.F., Oudejans, J.J., Vos, W., ten Berge, R.L. and Meijer, C.J. (2002) "Apoptosis in B-cell lymphomas and reactive lymphoid tissues always involves activation of caspase 3 as determined by a new in situ detection method", J. Pathol. 196, 307-315.
69. de Murcia, G. and Menissier-de Murcia, J.M. (1994) "Poly (ADP-ribose) polymerase: a molecular nick sensor", Trends Biochem. Sci. 19, 172-176.
70. Lazebnik, Y.A., Kaufmann, S.H., Desnoyers, S., Poirier, G.G. and Earnshaw, W.C. (1994) "Cleavage of poly(ADP-ribose) polymerase by proteinase with properties like ICE", Nature 371, 346-347.
71. Li, X. and Darzynkiewicz, Z. (2000) "Cleavage of poly (ADP-ribose) polymerase measured in situ in individual cells: relationship to DNA fragmentation and cell cycle position during apoptosis", Exp. Cell Res. 255, 125-132.
72. Bedner, E., Smolewski, P., Amstad, P. and Darzynkiewicz, Z. (2000) "Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation", Exp. Cell Res. 259, 308-313.
73. Smolewski, P., Bedner, E., Du, L., Hsieh, T.C., Wu, J.M., Phelps, D.J. and Darzynkiewicz, Z. (2001) "Detection of caspases activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry", Cytometry 44, 73-82.
74. Szmigielska-Kaplon, A., Smolewski, P., Najder, M. and Robak, T. (2002) "Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia", Ann. Hematol. 81, 508-513.
75. Darzynkiewicz, Z. and Barnard, E.A. (1966) "Specific proteases of mast cells", Nature 212, 1198-1203.
76. Smolewski, P., Grabarek, J., Halicka, H.D. and Darzynkiewicz, Z. (2002) "Assay of caspases activation in situ combined with probing plasma membrane integrity detects three distinct stages of apoptosis", J. Immunol. Methods 265, 111-121.
77. Kerr, J.F.R., Winterford, C.M. and Harmon, V. (1994) "Apoptosis Its significance in cancer and cancer therapy", Cancer 73, 2013-2026.
78. Vaux, D.L. and Korsmayer, S.J. (1999) "Cell death in development", Cell 96, 245-254.
79. Li, X., Gong, J., Feldman, E., Seiter, K., Traganos, F. an Darzynkiewicz, Z. (1994) "Apoptotic cell death during treatment of leukemias", Leuk. Lymphoma 13, 65-72.
80. Seiter, K., Feldman, E.J., Halicka, H.D., Traganos, F. Darzynkiewicz, Z., Lake, D. and Ahmed, T. (1997) "Phase I clinical and laboratory evaluation of topotecan and cytarabine in patients with acute leukemia", J. Clin. Oncol. 15, 44-51.
81. Seiter, K., Feldman, E.J., Traganos, F., et al. (1995) "Evaluation in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study with Paclitaxel", Leukemia 9, 1851-1856.
82. Darzynkiewicz, Z., Bedner, E. and Traganos, F. (2001) "Difficulties and pitfalls in analysis of apoptosis", Methods Cel Biol. 263, 527-546.
83. Darzynkiewicz, Z., Juan, G., Li, X., Murakami, T. and Traganos, F. (1997) "Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis)", Cytometry 27, 1-20.
84. Ormerod, M.G. (1998) "The study of apoptotic cells by flow cytometry", Leukemia 12, 1013-1025.
85. Smolewski, P., Grabarek, J., Phelps, D.J. and Darzynkiewicz, Z, (2001) "Stathmo-apoptosis: arresting apoptosis by fluorochrome-labeled inhibitor of caspases", Int. J. Oncol. 19, 657-663.
86. Smolewski, P., Grabarek, J. and Darzynkiewicz, Z. (2002) "Kinetics of HL-60 cell entrance to apoptosis during treatment with TNF-alfa or camptotecin assayed by the stathmoapoptosis method", Cytometry 47, 143-149.
87. Lin, C.W., Manshouri, T., Jilani, I., Neuberg, D., Patel, K., Kantarjian, H., Andreeff, M., Estrov, Z., Beran, M., Keating, M., Estey, E. and Albitar, M. (2002) "Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome", Leuk. Res. 26, 551-559.
88. Liu, L., Eby, M., Rathore, N., Sinke, S.K., Kumar, A. and Chaudhary, P.M. (2002) "The human herpes virus8-encoded viral FLICE inhibitory protein physically associated with and persistently activates the Ikappa B kinase complex", J. Biol. Chem. 277, 13745-137451.
89. Gaide, O., Martinon, F., Micheau, O., Bonnet, D., Thome, M. and Tschopp, J. (2001) "Carmal, a CARD-containing binding partner of Bc110, induces phosphorylation and NF-kappaB activation", FEBS Lett. 496, 121-127.
90. Schneider, C. and Hübinger, G. (2002) "Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family", Leuk. Lymphoma 43, 1355-1366.
91. Snow, A.L., Chen, L.J., Nepomuceno, R.R., Krams, S.M., Esquivel, C.O. and Martinez, O.M. (2001) "Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling", J. Immunol. 167, 5404-5411.
92. Dales, J.P., Palmerini, F., Devilard, E., Hassoun, J., Birg, F. and Xerri, L. (2001) "Caspases: conductors of the cell death machinery in lymphoma cells", Leuk. Lymphoma 41, 247-253.
93. Serafeim, A., Grafton, G., Chamba, A., Gregory, C.D., Blakely, R.D., Bowery, N.G., Barnes, N.M. and Gordon, J. (2002) "5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors", Blood 99, 2545-2553.
94. Schrantz, N., Auffredou, M.T., Bourgeade, M.F., Besnault, L., Leca, G. and Vazquez, A. (2001) "Zinc-mediated regulation of caspases activity: dose-dependent inhibition or activation of caspase-3 in the human Burkitt lymphoma B cells (Ramos)", Cell Death Differ. 8, 152-161.
95. Besnault, I., Schrantz, N., Auffredou, M.T., Leca, G., Bourgeade, M.F. and Vazquez, A. (2001) "B cell cross-linking triggers a caspase-8-dependent apoptotic pathway that is independent of the death effector domain of Fas-associated death domain protein", J. Immunol. 167, 733-740.
96. Herold, M.J., Kuss, A.W., Kraus, C. and Berberich, I. (2002) "Mitochondria-dependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cells", J. Immunol. 168, 3902-3909.
97. Armstrong, J.S., Hornung, B., Lecane, P., Jones, D.P. and Knox, S.J. (2001) "Rotenone-induced G2/M cell cycle arrest and apoptosis in a human B lymphoma cell line PW", Biochem. Biophys. Res. Commun. 289, 973-978.
98. Totth, A., Sebestyen, A., Barna, G., Nagy, K., Gondor, A., Bocsi, J., Mihalik, R., Petak, I., Houghton, J. and Kopper, L. (2001) "TGF beta 1 induces caspase-dependent but death-receptor independent apoptosis in lymphoid cells", AntiCancer Res. 21, 1207-1212.
99. Jiang, A. and Clark, E.A. (2001) "Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B-cell apoptosis", J. Immunol. 166, 6025-6033.
100. Schaich, M. and Illmer, T. (2002) "Mdr1 gene expression and mutations in Ras proto-oncogenes in acute myeloid leukemia", Leuk. Lymphoma 43, 1345-1354.
101. Kappelmayer, J., Karashi, E., Telek and Jakab, K. (2002) "Pros and cons on how to measure multidrug resistance in leukemias", Leuk. Lymphoma 43, 711-717.
102. ten Berge, R.L., Meijer, C.J., Dukers, D.F., Kummer, J.A., Bladergreon, B.A., Vos, W., Hack, C.E., Ossenkoppele, G.J. and Oudejans, J.J. (2002) "Expresions levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma", Blood 99, 4540-4546.
103. Suvas, S., Singh, V., Sahdev, S., Vohra, H. and Agrewala, J.N. (2002) "Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma", J. Biol. Chem. 277, 7766-7775.
104. Keating, M.J. (1999) "Chronic lymphocytic leukemia", Semin. Oncol. 26(Suppl. 14), 107-114.
105. King, D., Pringle, J.H., Hutchinson, M. and Cohen, G.M. (1998) "Processing/activation of caspases, -3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cells", Leukemia 12, 1553-1560.
106. Stoetzer, O.J., Pogrebniak, A., Scholz, M., Pelka-Fleischer, R., Gullis, E., Darsow, M., Nussler, V. and Wilmanns, W. (1999) "Drug-induced apoptosis in chronic lymphocytic leukemia", Leukemia 13, 1873-1880.
107. Jones, D.T., Ganeshaguru, K., Virchis, A.E., Folarin, N.I., Lowdell, M.W., Mehta, A.B., Prentice, H.G., Hoffbrand, A.V. and Wickremasinghe, R.G. (2001) "Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation", Blood 98, 2800-2807.
108. Bellosillo, B., Villamor, N., Lopez-Guillermo, A., Marce, S., Bosch, F., Campo, E., Montserrat, E. and Colomer, D. (2002) "Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia", Blood 100, 1810-1816.
109. Wall, N.R., Beck, F.W., Al-Katib, A.M. and Mohammad, R.M. (2001) "Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell line", J. Drug Target. 9, 329-339.
110. Chandra, J., Mansson, E., Gogvadze, V., Kaufmann, S.H., Albertoni, F. and Orrenius, S. (2002) "Resistance of leukemic cells to 2-chlorodeoxyadenosisne is due to a lack of calcium-dependent cytochrome c release", Blood 99, 655-663.
111. Pedersen, I.M., Kitada, S., Schimmer, A., Kim, Y, Zapata, J.M., Charboneau, L., Rassenti, L., Andreeff, M., Bennett, F., Sporn, M.B., Liotta, L.D., Kipps, T.J. and Reed, J.C. (2002) "The triterpenoid CDDO induces apoptosis in refractory CLL B cells", Blood 100, 2965-2972.
112. MacFarlane, M., Harper, N., Snowden, R.T., Dyer, M.J., Barnett, G.A., Pringle, J.H. and Cohen, G.M. (2002) "Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia", Oncogene 21, 6809-6818.
113. Min, R., Li, Z., Epstein, J., Barlogie, B. and Yi, Q. (2002) "Beta(2)-microglobulin as a negative growth regulator of myeloma cells", Br. J. Haematol. 118, 495-505.
114. Pene, F., Claessens, Y.E., Muller, O., Viguie, F., Mayeux, P., Dreyfus, F., Lacombe, C. and Bouscary, D. (2002) "Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma", Oncogene 21, 6587-6597.
115. Hideshima, T., Mitsiades, C., Akiyama, M., Hayashi, T., Chauhan, D., Richardson, P., Schlossman, R., Podar, K., Munshi, N.C., Mitsiades, N. and Anderson, K.C. (2002) "Molecular mechanisms mediating anti-myeloma activity of proteasome inhibitor PS-341", Blood Sep 26, In press.
116. Minami, R., Muta, K., Ilseung, C., Abe, Y., Nishimura, J. and Nawata, H. (2000) "Interleukin-6 sensitizes multiple myeloma cell lines for apoptosis induced by interferon-alpha", Exp. Hematol. 28, 244-255.
117. Choi, Y., Zhang, J., Murga, C., Yu, H., Koller, E., Monia, B.P., Gutkind, J.S. and Li, W. (2002) "PTEN, but not SHIP and SHIP2, suppresses the P13K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells", Oncogene 21, 5289-5300.
118. Chauhan, D., Catley, L., Hideshima, T., Li, G., Leblanc, R., Gupta, D., Sattler, M., Richardson, P., Schlossman, R.L., Podar, K., Weller, E., Munshi, N. and Anderson, K.C. (2002) "2-Methoxy-estradiol overcomes drug resistance in multiple myeloma cells", Blood 100, 2187-2194.
119. Chauhan, D., Hideshima, T., Rosen, S., Reed, J.C., Kharbanda, S. and Anderson, K.C. (2001) "Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells", J. Biol. Chem. 276, 24453-24456.
120. Chen, Q., Gong, B., Mahmoud-Ahmed, A.S., Zhou, A., Hsi, E.D., Hussein, M. and Almasan, A. (2001) "Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma", Blood 98, 2183-2192.
121. Chen, Q., Gong, B. and Almasan, A. (2000) "Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis", Cell Death Differ. 7, 227-233.
122. Mitsiades, N., Mitsiades, C.S., Poulaki, V., Chauhan, D., Richardson, P.G., Hideshima, T., Munshi, N.C., Treon, S.P. and Anderson, K.C. (2002) "Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications", Blood 99, 4525-4530.
123. Gupta, D., Podar, K., Tai, Y.T., Lin, B., Hideshima, T., Akiyama, M., LeBlanc, R., Catley, L., Mitsiades, N., Mitsiades, C., Chauhan, D., Munshi, N.C. and Anderson, K.C. (2002) "Beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells", Exp. Hematol. 30, 711-720.
124. Frassanito, M.A., Cusmai, A., Piccoli, C. and Dammacco, F. (2002) "Manumycin inhibits farnesyltransferase and induces apoptosis of drug-resistant interleukin 6-producing myeloma cells", Br. J. Haematol. 118, 157-165.
125. Mitsiades, N., Mitsiades, C.S., Poulaki, V., Anderson, K.C. and Treon, S.P. (2001) "Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias", Expert Opin. Investig. Drugs 10, 1521-1530.
126. Jazirehi, A.R., Ng, C.P., Gan, X.H., Schiller, G. and Bonavida, B. (2001) "Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis", Clin. Cancer Res. 7, 3874-3883.
127. Jia, P., Chen, G., Huang, X., Cai, X., Yang, J., Wang, L., Zhou, Y., Shen, Y., Zhou, L., Yu, Y., Chen, S., Zhang, X. and Wang, Z. (2001) "Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3", Chin. Med. J. 114, 19-24.
128. Gartenhaus, R.B., Prachand, S.N., Pamaqua, M., Li, Y. and Gordon, L.I. (2002) "Arsenic trioxide cytotoxicity in steroid and chemotherapy-resistant myeloma cell lines: enhancement of apoptosis by manipulation of cellular redox state", Clin. Cancer Res. 8, 566-572.
129. Oliver, L., Vavasseur, F., Mahe, B., Perrin, R, Harousseau, J.L., Meflah, K. and Vallette, F.M. (2002) "Assessment of caspase activity as a possible prognostic factor in acute myeloid leukaemia", Br. J. Haematol. 118, 434-437.
130. Hirst, W., Buggins, A. and Mufti, G. (2002) "Central role of leukemia-derived factors in the development of leukemia-associated immune dysfunction", Hematol. J. 2, 2-17.
131. Svingen, P.A., Tefferi, A., Kottke, T.J., Kaur, G., Narayanan, V.L., Sausville, E.A. and Kaufmann, S.H. (2000) "Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro", Clin. Cancer Res. 6, 237-249.
132. Campos, L., Sabido, O., Viallet, A., Vasselon, C. and Guyotat, D. (1999) "Expression of apoptosis-controlling proteins in acute leukemia cells", Leuk. Lymphoma 33, 499-509.
133. Belaud-Rotureau, M.A., Durrieu, F., Labroille, G., Lacombe, F., Fitoussi, O., Agape, P., Marit, G., Reiffers, J. and Belloc, F. (2000) "Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment", Leukemia 14, 1266-1275.
134. Dunusii-Joannopoulos, K. (2002) "The combination of chemotherapy and systemic immunotherapy and the concept of cure in murine Leuk. Lymphoma", Leuk. Lymphoma 43, 2075-2082.
135. Boudard, D., Sordet, O., Vasselon, C., Revol, V., Bretheas, M.F., Freyssenet, D., Viallet, A., Piselli, S. and Guyotat, D. (2000) "Expression and activity of caspases 1 and 3 in myelodysplastic syndromes", Leukemia 14, 2045-2051.
136. Lin, C.W., Manshouri, T., Jilani, I., Neuberg, D., Patel, K., Kantarjian, H., Andreeff, M., Estrov, Z., Beran, M., Keating, M., Estey, E. and Albitar, M. (2002) "Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome", Leuk. Res. 26, 551-559.
137. Claessens, Y.E., Bouscary, D., Dupont, J.M., Picard, F., Melle, J., Gisselbrecht, S., Lacombe, C., Dreyfus, F., Mayeux, P. and Fontenay-Roupie, M. (2002) "In vitro proliferation and differentiation of erythroid progenitors from patients with myelopdyplastic syndromes: evidence for Fas-dependent apoptosis", Blood 99, 1594-1601.
138. Boudard, D., Vasselon, C., Bretheas, M.F., Jaubert, J., Mournier, C., Reynaud, J., Viallet, A., Chautard, S., Guyotat, D. and Campos, L. (2002) "Expression and prognostic significant of Bcl-2 family proteins myelodysplastics syndromes", Am. J. Hematol. 70, 115-125.
139. Zang, Y., Goodwin, R.G., Loken, M.R., Bryant, E. and Deeg, J. (2001) "Expression of tumor necrosis factor-mediated apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis", Blood 98, 3058-3065.
140. Daley, G.Q., Van Etten, R.A. and Baltiomore, D. (1990) "Blast crisis in a murine model of chronic myelogenous leukemia", Science 247, 824-830.
141. Lugo, T.C., Pendergarst, A.M., Muller, A.J. and Witte, O.N. (1990) "Tyrosine kinase activity and transformation potency of bcr-abl oncogene products", Science 247, 1079-1082.
142. Dan, S., Naito, M., Seimiya, H., Kizaki, A., Mashima, T. and Tsuruo, T. (1999) "Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cells", Oncogene 18, 1277-1283.
143. Dan, S., Naito, M. and Tsuruo, T. (1998) "Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR - ABL tyrosine kinase, CGP 57148", Cell Death Differ. 5, 710-715.
144. Oetzel, C., Jonuleit, T., Gotz, A., van der Kuip, H., Michels, H., Duyster, J., Hallek, M. and Aulitzky, W.E. (2000) "The tyrosine kinase inhibitor CGP 57148 (STI 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X", Clin. Cancer Res. 6, 1958-1968.
145. Druker, B.J., Sawyers, C.L., Kantarijan, H., Resta, D.J., Reese, S.F., Ford, J.M., Capdeville, R. and Talpaz, M. (2001) "Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome", N. Engl. J. Med. 344, 1038-1042.
146. Druker, B.J., Talpaz, M., Resta, D.J., Peng, B., Buchdunger, E., Ford, J.M., Lydon, N.B., Kantarijan, H., Capdeville, R., Ohno-Jones, S. and Sawyers, C.L. (2001) "Efficiacy and safety of a specific inhibitor BCR-ABL tyrosine kinase in chronic myeloid leukemia", N. Engl. J. Med. 344, 1031-1037.
147. Klejman, A., Rushen, L., Morrione, A., Slupianek, A. and
148. Shim, M.J., Kim, H.J., Yang, S.J., Lee, I.S., Choi, H.I. and Kim, T. (2002) "Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase", J. Biochem. Mol. Biol. 35, 377-383.
149. La Rosee, P., Johnson, K., O'Dwyer, M.E. and Druker, B.J. (2002) "In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia", Exp. Hematol. 30, 729-737.
150. Gangemi, R.M., Santamaria, B., Bargellesi, A., Cosulich, E. and Fabbi, M. (2000) "Late apoptotic effects of taxanes on K562 erythroleukemia cells: apoptosis is delayed upstream of caspase-3 activation", Intern. J. Cancer 85, 527-533
151. Mc Gee, M.M., Campiani, G., Ramunno, A., Fattorusso, C., Nacci, V., Lawler, M., Williams, D.C. and Zisterer, D.M. (2001) "Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-abl", J. Pharmacol. Exp. Ther. 296, 31-40.
152. Wu, J., Suzuki, H., Zhou, Y.W., Liu, W., Yoshihara, M., Kato, M., Akhand, A.A., Hayakawa, A., Takeuchi, K., Hossain, K., Kurosawa, M. and Nakashima, I. (2001) "Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines", J. Cell. Biochem. 82, 200-214.
153. Clodi, K., Kliche, K.O., Zhao, S., Weidner, D., Schenk, T., Consoli, U., Jiang, S., Snell, V. and Andreeff, M. (2000) "Cell-surface exposure of phosphatidylserine correlates with the stage of fludarabine-induced apoptosis in chronic lymphocytic leukemia and expression of apoptosis-regulating genes", Cytometry 40, 19-25.
154. Chow, K.U., Rummel, M.J., Weichmann, E., Ries, J., Jantschke, P., Boehrer, S., Pourebrahim, F., Napieralski, S., Stein, J., Martin, H., Hoelzer, D. and Mitron, P.S. (2000) "Induction of apoptosis by 2-chloro2-deoxyadenosine (2-CdA) alone and in combination with other cytostatic drugs: synergistic effect on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone", Leuk. Lymphoma 36, 559-567.
155. Bellosillo, B., Colomer, D., Pons, G. and Gil, J. (1998) "Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B-chronic lymphocytic leukaemia cells", Br. J. Haematol. 100, 142-146.
156. Robak, T. (2001) "Cladribine in the treatment of chronic lymphocytic leukemia", Leuk. Lymphoma 40, 551-564.
157. Genini, D., Budihardjo, I., Plunkett, W., Wang, X., Carrera, C.J., Cottam, H.B., Carson, D.A. and Leoni, L.M. (2000) "Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway", J. Biol. Chem. 275, 29-34.
158. Marzo, I., Perez-Galan, P., Giraldo, P., Rubio-Felix, D., Anel, A. and Naval, J. (2001) "Cladribine induces apoptosis in human leukemia cells by caspase-dependent and -independent pathways acting on mitochondria", Biochem. J. 359, 537-546.
159. Van Den Neste, E., Cardoen, S., Husson, B., Rosier, J.F., Delacauw, A., Ferrant, A., Van den Berghe, G. and Bontemps, F. (2002) "2-Chloro-2′-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes", Leukemia 16, 36-43.
160. Coiffier, B. (2002) "Rituximab in the treatment of diffuse large B-cell lymphomas", Semin. Oncol. 29(Suppl. 2), 30-35.
161. Keating, M.J., O'Brien, S. and Albitar, M. (2002) "Emerging information on the use of rituximab in chronic lymphocytic leukemia", Semin. Oncol. 29(Suppl. 2), 70-74.
162. Alas, S., Ng, C.P. and Bonavida, B. (2002) "Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma", Clin. Cancer Res. 8, 836-845.
163. Bellosillo, B., Villamor, N., Lopez-Guillermo, A., Marce, S., Esteve, J., Campo, E., Colomer, D. and Montserrat, E. (2001) "Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species", Blood 98, 2771-2777.
164. Chow, K.U., Sommerlad, W.D., Boehrer, S., Schneider, B., Seipelt, G., Rummel, M.J., Hoelzer, D., Mitrou, P.S. and Weidmann, E. (2002) "Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases", Haematologica 87, 33-43.
165. Byrd, J.C., Kitada, S., Flinn, J.W., Aron, J.L., Pearson, M., Lucas, D. and Reed, J.C. (2002) "The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction", Blood 99, 1038-1043.
166. Smolewski, P., Szmigielska-Kaplon, A., Cebula, B., Sobczak, A., Darzynkiewicz, Z. and Robak, T. (2002) "Pro-apoptotic effect of rituximab alone or in combination with purine nucleoside analogues on B-CLL chronic lymphocytic leukemia cells measured by fluorochrome labeled inhibitors of caspases (FLICA) assay", Blood 100 (abstr.), 1503, 2002 Annual Meeting of the American Society of Hematology, December 2002.
167. Shan, D., Gopal, A.K. and Press, O.W. (2001) "Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells", Clin. Cancer Res. 7, 2490-2495.
168. Mateo, V., Lagneaux, L., Bron, D., Biron, G., Armant, M., Delespesse, G. and Sarfati, M. (1999) "CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia", Nat. Med. 5, 1277-1284.
169. Chu, R, Wierda, W.G. and Kipps, T.J. (2000) "CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes", Blood 95, 3853-3858.
170. Chu, P., Deforce, D., Pedersen, I.M., Kim, Y., Kitada, S., Reed, J.C. and Kipps, T.J. (2002) "Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia", Proc. Natl Acad. Sci. USA 99, 3854-3859.
171. Almond, J.B., Snowden, R.T., Hunter, A., Dinsdale, D., Cain, K. and Cohen, G.M. (2001) "Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an approximately 700 kDa Apaf-1 containing apoptosome complex", Leukemia 15, 1388-1397.
172. Lagneaux, L., Delforge, A., Carlier, S., Massy, M., Bernier, M. and Bron, D. (2001) "Early induction of apoptosis in B-chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase-3 and no protection by survival factors", Br. J. Haematol. 112, 344-352.
173. Nabha, S.M., Mohammad, R.M., Dandashi, M.H., Coupaye-Gerard, B., Aboukameel, A., Pettit, G.R. and Al-Katib, A.M. (2002) "Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose)polymerase cleavage", Clin. Cancer Res. 8, 2735-2741.
174. Sievers, E.L. (2001) "Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse", Expert Opin. Biol. Ther. 1, 893-901.
175. Sievers, E.L., Larson, R.A., Stadtmauer, E.A., Estey, E., Lowenberg, B., Dombret, H., Karanes, C., Theobald, M., Bennett, J.M., Sherman, M.L., Berger, M.S., Eten, C.B., Loken, MR., van Dongen, J.J., Bernstein, I.D. and Appelbaum, F.R. (2001) "Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse", J. Clin. Oncol. 19, 3244-3254.
176. Verma, A. and Platanias, L.C. (2002) "Signalling via the interferon-α receptor in chronic myelogenous leukemia cells", Leak. Lymphoma 43, 703-709.
177. Voutsadakis, I.A. (2000) "Interferon-alpha and the pathogenesis of myeloproliferative disorders", Med. Oncol. 17, 249-257.
178. Ben Jilani, K.E., Akarid, K., Arnoult, D., Petit, F., Baert, E., Gaillard, J.P., Ameisen, J.C. and Estaquier, J. (2001) "Gamma-interferon induces apoptosis of the B lymphoma WEHI-279 cell line through a CD95/CD95L-independent mechanism", Eur Cytokine Network 12, 587-596.
179. Distelhorst, C.W. (2002) "Recent insights into the mechanism of glucocorticosteroid-induced apoptosis", Cell Death Differ. 9, 6-19.
180. Ergin, M., Denning, M.F., Izban, K.F., Amin, H.M., Martinez, R.L., Saeed, S. and Alkan, S. (2001) "Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein", Exp. Hematol. 29, 1082-1090.
181. Lovborg, H., Martinsson, P., Gullbo, J., Ekelund, S., Nygren, P. and Larsson, R. (2002) "Modulation of pyridyl cyanoguanidine (CHS 828) induced cytotoxicity by 3-aminobenzamide in U-937 GTB cells", Biochem. Pharmacol. 63, 1491-1498.
182. Heimli, H., Giske, C., Naderi, S., Drevon, C.A. and Hollungm, K. (2002) "Eicosapentaenoic acid promotes apoptosis in Ramos cells via activation of caspase-3 and -9", Lipids 37, 797-802.
183. Wieder, T., Prokop, A., Bagci, B., Essmann, F., Bernicke, D., Schulze-Osthoff, K., Dorken, B., Schmalz, H.G., Daniel, P.T. and Henze, G. (2001) "Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts", Leukemia 15, 1735-1742.
184. Fujino, M., Li, X.K., Kitazawa, Y., Guo, L., Kawasaki, M., Funeshima, N., Amano, T. and Suzuki, S. (2002) "Distinct pathways of apoptosis triggered by FFY720, etoposide, and anti-Fas antibody in human T-lymphoma cell line (Jurkat cells)", J. Pharmacol. Exp. Ther. 300, 939-945.
185. Grubb, D.R., Ly, J.D., Vaillant, F., Johnson, K.L. and Lawen, A. (2001) "Mitochondrial cytochrome c release is caspase-dependent and does not involve mitochondrial permeability transition in didemnin B-induced apoptosis", Oncogene 20, 4085-4094.
186. Rapoport, A.P., Simons-Evelyn, M., Chen, T., Sidell, R., Luhowskyj, S., Rosell, K., Obrig, T., Hicks, D., Hinkle, P.M., Nahm, M., Insel, R.A. and Abboud, C.N. (2001) "Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes", Blood Cells Mol. Disorders 27, 610-624.
187. Witzig, T.E., Timm, M., Stenson, M., Svingen, P.A. and Kaufmann, S.H. (2000) "Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents", Clin. Cancer Res. 6, 681-692.
188. Castiglioni, P., Martin-Fontecha, A., Milan, G., Tomajer, V., Magni, F., Michaelsson, J., Rugarli, C., Rosato, A. and Bellone, M. (2002) "Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cells", Cancer Res. 62, 1116-1122.
189. Belka, C., Schmid, B., Marini, P., Durand, E., Rudner, J., Faltin, H., Bamberg, M., Schulze-Osthoff, K. and Budach, W. (2001) "Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL", Oncogene 20, 2190-2196.
190. Wen, J., Ramadevi, N., Nguyen, D., Perkins, C., Worthingogn, E. and Bhalla, K. (2000) "Antileukemic drugs increase death receptor 5 levels and enhance Apo-2/L-induced apoptosis of human acute leukemia cells", Blood 96, 3900-3906.
191. Secchiero, P., Gonelli, A., Celeghini, C., Mirandola, P., Guidotti, L., Visani, G., Capitani, S. and Zauli, G. (2001) "Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies", Blood 98, 2220-2228.
192. Guo, F., Nimmanapalll, R., Paranawithana, S., Wittman, S., Griffin, D., Bali, P., O'Bryan, E., Fumero, C., Wang, H.G. and Bhalla, K. (2002) "Ectopic overexpression of second-mitochondria derived acivator of caspases (Smac/DIABLO) and cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B-derivate- (BMS 247550) and Apo-2L/TRAIL-induced apoptosis", Blood 99, 3419-3426.